18 results
PRE 14A
SQZB
SQZ Biotechnologies Co
10 Apr 23
Preliminary proxy
4:31pm
, on a consulting, project and expert witness basis. Before that, from March 2011 to November 2016, Mr. Knopf served as Senior Vice President … . and Patrick V.J.J. Vink, M.D. is an “audit committee financial expert” as defined by applicable SEC rules and has the requisite financial
DEF 14A
SQZB
SQZ Biotechnologies Co
26 Apr 21
Definitive proxy
5:00pm
, on a consulting, project and expert witness basis. Before that, from March 2011 to November 2016, Mr. Knopf served as Senior Vice President and General Counsel … . is an “audit committee financial expert” as defined by applicable SEC rules and has the requisite financial sophistication as defined under the applicable
10-K
vvlu1uyrl113uheeh09
18 Mar 21
Annual report
6:31am
424B4
h3thsu8ck ikppp
12 Feb 21
Prospectus supplement with pricing info
5:10pm
DRS
ja8g8n0cl
1 Feb 21
Draft registration statement
12:00am
424B4
jg4gd 5bu8txvkc3
30 Oct 20
Prospectus supplement with pricing info
4:54pm
S-1
EX-10.7
os5usa 3258c
9 Oct 20
IPO registration
4:59pm
S-1
s1qp78nz2lg868aoo
9 Oct 20
IPO registration
4:59pm
DRS/A
sb33hn3a0zf5y5wuzp
25 Sep 20
Draft registration statement (amended)
12:00am
DRS/A
363z2lmb8fdyaqi
28 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.7
mdbitxq8u 96z
28 Aug 20
Draft registration statement (amended)
12:00am
DRS
25rq9dfk
21 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next